Breaking news - Generics knock out anti-depressant patent
Submitted by Suzy Madar on 31 October 2011 - 8:39am.
The Full Court of the Federal Court of Australia on Friday upheld a claim by Alphapharm (together with Sigma and Generic Health) that claims 1 to 17 and 27 of Wyeth's patent relating to venlafaxine, an anti-depressant used in the treatment of depression, are invalid.
Mallesons acted for Alphapharm in the proceeding.
Partner: